A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021 - Trial NCT05762094
Access comprehensive clinical trial information for NCT05762094 through Pure Global AI's free database. This phase not specified trial is sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School and is currently Recruiting. The study focuses on Bacterial Infections. Target enrollment is 1000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Timeline & Enrollment
N/A
Mar 01, 2023
Dec 01, 2023
Primary Outcome
Mortality,Attainment of Target Trough Concentration
Summary
Patients may benefit from the personalized carbapenem dosing strategy based on
 pharmacokinetics. The objective of this study is to retrospectively review and analyze the
 clinical outcomes of patients with different dosing strategy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05762094
Non-Device Trial